Arcadia Biosciences Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 69
Employees
  • Stock Symbol
  • RKDA
Stock Symbol
  • Investments
  • 8
  • Share Price
  • $0.86
  • (As of Monday Closing)

Arcadia Biosciences General Information

Description

Arcadia Biosciences Inc is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. It has used advanced breeding techniques to develop these proprietary innovations which it is now commercializing through the sales of seed and grain food ingredients and products, hemp extracts, trait licensing, and royalty agreements.

Contact Information

Website
www.arcadiabio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 202 Cousteau Place
  • Suite 105
  • Davis, CA 95618
  • United States
+1 (530) 000-0000

Arcadia Biosciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcadia Biosciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.86 $0.94 $0.78 - $6.40 $19.1M 22.2M 1.03M $0.69

Arcadia Biosciences Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 10,877 34,079 19,370 (9,464)
Revenue 11,739 8,034 1,169 1,464
EBITDA 3,034 (5,441) (28,672) (13,316)
Net Income 3,520 (4,655) (28,805) (13,480)
Total Assets 59,228 47,348 32,574 24,024
Total Debt 3,810 9,352 2,239 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arcadia Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arcadia Biosciences‘s full profile, request access.

Request a free trial

Arcadia Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Arcadia Biosciences Inc is engaged in science-based approaches to developing high-value crop improvements primarily in w
Biotechnology
Davis, CA
69 As of 2020
00000
000000000 00000

000000

met, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000
Emeryville, CA
000 As of 0000
00.000
000000000 00.000

00000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Vancouver, Canada
00 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arcadia Biosciences Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris Formerly VC-backed Emeryville, CA 000 00.000 000000000 00.000
00000000000 000000 Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 000.00
000 0000 000 00000 Corporate Backed or Acquired York, United Kingdom 000 0000 000000000000 0000
000000000 Venture Capital-Backed Lutherville Timonium, MD 0 000.00 0000000000 0 000.00
0000000000 Venture Capital-Backed Lexington, KY 0 00000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Arcadia Biosciences Patents

  • 96

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 10

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Arcadia Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200291415-A1 Soybeans with reduced antinutritional factor content Pending 15-Mar-2019 00000000
JP-2018518983-A Wheat with glyphosate resistance due to changes in 5-enolpyruvylshikimate-3 phosphate synthase Pending 02-Jul-2015 0000000000
AU-2016288257-B2 Wheat having resistance to glyphosate due to alterations in 5-enol-pyruvylshikimate-3 phosphate synthase Active 02-Jul-2015 0000000000 0
CA-2990679-A1 Wheat having resistance to glyphosate due to alterations in 5-enol-pyruvylshikimate-3 phosphate synthase Pending 02-Jul-2015 0000000000
AU-2016288257-A1 Wheat having resistance to glyphosate due to alterations in 5-enol-pyruvylshikimate-3 phosphate synthase Granted 02-Jul-2015 A01H6/4678
To view Arcadia Biosciences’s complete patent history, request access »

Arcadia Biosciences Executive Team (19)

Name Title Board Seat Contact Info
Kevin Comcowich Chief Executive Officer & Chairman
Pamela Haley Chief Financial Officer
Randall Shultz Ph.D Chief Technology Officer, Technology
Laura Pitlik Chief Marketing Officer, Marketing
Chris Cuvelier Chief Growth Officer
You’re viewing 5 of 19 executive team members. Get the full list »

Arcadia Biosciences Board Members (17)

Name Representing Role Since
Albert Bolles Ph.D Self Board Member 000 0000
Amy Yoder Self Board Member 000 0000
Deborah Carosella Arcadia Biosciences Board Member 000 0000
Eric Rey Self Board Member 000 0000
Gregory Waller Arcadia Biosciences Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Arcadia Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcadia Biosciences Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000 21-Sep-2021 0000 00000 00.00 Drug Discovery
0000 00000000 17-May-2021 0000000000 Personal Products 0000000 0
00000 0000000 17-May-2021 0000000000 Personal Products 0000000 0
0000000 19-Apr-2021 0000000000 Cultivation 0000000 0
Industrial Seed Innovations (commercial and genetic assets) 01-Sep-2020 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Arcadia Biosciences Subsidiaries (3)

Company Name Industry Location Founded
Lief Holdings, LLC (Soul Spring) Personal Products Los Angeles, CA 2019
00000 00000000 Personal Products Los Angeles, CA 0000
0000000 Cultivation Barcelona, Spain 0000
To view Arcadia Biosciences’s complete subsidiaries history, request access »

Arcadia Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 28-Feb-2012 00000 0000000 Completed
  • 2 buyers
To view Arcadia Biosciences’s complete exits history, request access »